US · Healthcare

Zenas BioPharma, Inc. Common Stock (ZBIO)

Biotechnology

Zenas BioPharma, Inc. Common Stock (ZBIO) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for ZBIO

P/E ratio

25.00

Zenas BioPharma, Inc. Common Stock (ZBIO) — FAQ

What is ZBIO's P/E ratio?

The price-to-earnings (P/E) ratio for Zenas BioPharma, Inc. Common Stock (ZBIO) is 25.00 (data as of 2026-05-23).

Does Zenas BioPharma, Inc. Common Stock pay a dividend?

Dividend yield is not available in the current snapshot for Zenas BioPharma, Inc. Common Stock (ZBIO). Check the MyAverix Finance app for the latest dividend data.

What sector is Zenas BioPharma, Inc. Common Stock in?

Zenas BioPharma, Inc. Common Stock (ZBIO) is classified in the Healthcare sector (Biotechnology industry).

What exchange is ZBIO listed on?

ZBIO is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)